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Objective: To examine the association between cardiac autonomic dysfunction and 
high albumin:creatinine ratio (ACR) in adolescents with type 1 diabetes. 
Research Design and Methods: Adolescents recruited as part of a multicentre 
screening study (n=445, 49% female, aged 10-17 years, mean duration 6.9 years, 
mean HbA1c 8.4%, 68mmol/mol) underwent a 10-minute continuous ECG-recording 
for heart rate variability analysis. Time domain heart rate variability measures 
included: baseline heart rate, SDNN (standard deviation of the R-R interval), RMSSD 
(root mean squared difference of successive RR intervals); and spectral analysis 
included: sympathetic (low frequency) and parasympathetic (high frequency) 
components. Standardised ACR were calculated from 6 early morning urine 
collections using an established algorithm, reflecting age, gender and duration, and 
stratified into ACR tertiles where the upper tertile reflects higher nephropathy risk. 
Results: The upper tertile ACR group had faster heart rate (76 vs 73bpm; p<0.01) 
and less heart rate variability (SDNN 68 vs 76ms, p=0.02; RMSSD 63 vs 71ms, 
p=0.04). HbA1c was 8.5% (69 mmol/mmol) in the upper tertile vs 8.3% (67mmol/mol) 
in the lower tertiles (p=0.07). In multivariable analysis, upper tertile ACR was 
associated with faster heart rate (β=2.5, CI 0.2 to 4.8; p=0.03) and lower RMSSD 
(β=-9.5, CI -18.2 to -0.8; p=0.03), independent of age and HbA1c.   
Conclusions: Adolescents at potentially higher risk for nephropathy show an 
adverse cardiac autonomic profile, indicating sympathetic overdrive, compared to the 
lower risk group. Longitudinal follow up of this cohort will further characterize the 
relationship between autonomic and renal dysfunction, and the impact of 
interventions in this population. 
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Cardiac autonomic dysfunction is an early subclinical complication of type 1 diabetes 
(1; 2). It is associated with microalbuminuria both in adults and adolescents (3; 4), 
and the progression of renal disease in adults (5; 6).  Power spectral analyses of 
heart rate variability allow more sensitive detection of cardiac autonomic changes 
than the conventional Ewing battery of tests based on dynamic cardiovascular 
manoeuvres (5; 7; 8). Recent studies utilising these modern methods have 
demonstrated that adverse changes in heart rate variability may be detected during 
adolescence in people with type 1 diabetes, and are primarily associated with poor 
glycemic control (1; 9; 10). However, there is a paucity of data on whether cardiac 
autonomic function is associated with early renal dysfunction, prior to the onset of 
microalbuminuria.   
 
Nephropathy risk in type 1 diabetes begins with a progressive increase in albumin 
excretion during adolescence, before the threshold for microalbuminuria is reached 
(11). Albumin excretion phenotype in children aged between 11-15 years, defined by 
albumin:creatinine ratio (ACR) tertile adjusted for age, gender and diabetes duration, 
has been shown to stratify into nephropathy risk (11). Since autonomic neuropathy is 
a risk factor for progression of renal disease in adults (5; 6), we hypothesised that 
adolescents with type 1 diabetes at higher risk of nephropathy would have an 
adverse cardiac autonomic profile compared to those at lower risk of nephropathy, 
independent of glycemic control. We therefore examined heart rate variability in 
young adolescents with type 1 diabetes stratified for nephropathy risk based on 
these previously validated ACR tertiles.  
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Research Design and Methods 
Adolescents with type 1 diabetes duration greater than one year (n=445, 49% 
female, aged 10-17 years) were recruited as part of the nephropathy screening to 
determine eligibility for the Adolescent Type 1 Diabetes Cardio-Renal Intervention 
Trial (AdDIT). AdDIT is a multicentre randomised controlled trial across the United 
Kingdom, Australia and Canada, where adolescents at risk of diabetic nephropathy, 
indicated by upper tertile ACR, are randomised to an angiotensin-converting-enzyme 
(ACE) inhibitor and/or ‘statin’ (HMG-CoA reductase inhibitor) or placebo (12). Data 
for the current study were collected prior to any intervention. This study was 
approved by the Human Research Ethics Committees of each participating centre. 
Informed consent was obtained from participants and their families.  
Participants underwent a 10-minute continuous ECG recording in supine position 
using the LabChart-Pro (ADInstruments, Sydney Australia). Measurements were 
taken in a quiet room, after the patients were rested for 10 minutes. All traces were 
reviewed and analysed by a single operator masked to patients’ clinical status. 
Traces were checked to ensure R-waves were adequately identified from artefacts 
and ectopic beats. The term “NN” is used in place of RR to emphasize the fact that 
the processed beats are normal sinus rhythm (ie. every QRS complex was preceded 
by a p-wave). Heart rate variability refers to the variations of heart rate and 
successive cardiac cycles, under the control of the autonomic nervous system. Time-
domain measures of overall heart rate variability included: mean heart rate, standard 
deviation of mean NN intervals (SDNN) and root mean squared difference of 
successive NN-intervals (RMSSD). Geometric-domain analysis was performed using 
triangular index (TI), total number of all NN intervals divided by the height of the 
histogram of all NN intervals measured on a discrete scale with bins of 7.8125 ms 
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(1/128 seconds). Frequency-domain measures included: low frequency (LF), defined 
as >0.04Hz and <0.15Hz, and high frequency (HF) components, defined as >0.15Hz 
and <0.4Hz, and the LF:HF ratio, considered to be an estimate of the relative 
sympathetic and parasympathetic balance (13). Age matched community controls 
(n=62; 45% female, age range 10-17 years) were contemporaneously recruited from 
healthy Sydney school-aged adolescents. 
 
All urine samples were analyzed centrally at The WellChild laboratory at The Evelina 
Children’s Hospital, London. Samples were stored at –70°C prior to shipping. Urine 
albumin was measured using laser immunonephelometry (Siemens BN Prospec) 
and for concentrations <2.1 mg/l by an enzyme linked immunoabsorbent assay 
(ELISA) (14). Urine creatinine was measured using a chromatographic stable isotope 
dilution electrospray mass spectrometry-mass spectrometry (MSMS) method. For 
each participant, two time-point ACR measures (mg/mmol), each based on three 
consecutive early morning samples at two separate visits, were averaged on the log 
ACR scale and the average residual calculated using age, gender and duration and 
the coefficients from the previously described linear regression model in the Oxford 
Regional Prospective Study of Childhood Diabetes (ORPS) cohort (11). Upper ACR 
tertile was assigned to residual value above 1.2, middle ACR tertile to values 
between 0.8 and 1.2, and lower ACR tertile to values below 0.8. For this study, the 
lower two tertiles were combined for analysis. 
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HbA1c was analysed locally at each centre, using DCCT aligned methods: HbA1c 
Variant analyser (Bio-Rad Laboratories, CA, USA), Adams Arkray Inc, (Kyoto, 
Japan), Vantage analyser, Siemens Diagnostics, Camberley UK or DCA 2000.  
 
Estimated glomerular filtration rate (eGFR) was calculated from the formula: eGFR 
(ml/min/1.73m2) = 42*height (cm)/plasma creatinine (μmol/l)(12). Lipid profile 
measurements (cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides) were 
measured using routine laboratory methods.  
 
Height and weight were measured to 0.1 cm and 0.1 kg. Height, weight and body 
mass index (BMI) standard deviation scores (SDS) were calculated according to the 
LMS method (15). Blood pressure was measured using Omran M6 blood pressure 
(all centres) and/or Dinamap (NSW) monitor using an appropriate sized cuff. Age 
and gender related percentiles and SDS for systolic and diastolic blood pressures 
were calculated according to published standards (16). Systolic hypertension was 
defined as systolic blood pressure above the 95th percentile for age and gender.  
 
Statistical analysis 
Descriptive data are summarised as mean (± standard deviation) for parametric 
data. Heart rate and heart rate variability parameters were normally distributed and 
analyzed as continuous variables. Urine albumin excretion groups (upper vs lower 
two tertiles) were analyzed as categorical variables. Mean differences between 
groups were compared using independent samples T-tests (diabetes versus 
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controls, ACR group upper vs lower tertiles). Marginal means for the ACR groups 
(upper vs lower tertiles) were evaluated at 11, 13, 15 and 17 years of age, and 
compared using ANOVA. Linear regression was used to model the association 
between ACR group and continuous ACR and heart rate or heart rate variability 
outcomes. Multivariable regression analysis was used to examine the association 
between ACR group and other clinical variables (age, HbA1c, BP, BMI SDS and 
lipids) with heart rate/heart rate variability outcomes. All statistical analyses were 
conducted using SPSS version 21.  
 
Results 
Participant characteristics  
Of the 445 participants who underwent heart rate variability testing, 217 (48%) were 
in the lower two tertiles for ACR (mean age 14.6 ±1.5 years) (Table 1). Adolescents 
in the high risk (upper tertile) group were slightly younger, and had shorter diabetes 
duration than those in the low risk (lower tertiles) group. There was no significant 
difference in gender, HbA1c or BMI SDS between the two groups. HDL-cholesterol 
and systolic blood pressure SDS were marginally higher in the upper tertile group. Of 
the 55/445 adolescents with systolic hypertension, 73% were in upper tertile whilst 
27% were in the lower tertiles (p<0.001).  
 
Standardised ACR as a continuous variable was significantly associated with HR 
(β=1.5, CI 0.4 to 2.7, p<0.01) and RMSSD – a measure of overall heart rate 
variability (β=-4.4, CI -8.4 to -0.3, p=0.03), which remained significant after adjusting 
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for age and HbA1c.  Systolic and diastolic blood pressures were not significant 
variables in the model. 
 
Comparison of heart rate variability in the diabetes subgroups: upper ACR 
tertile versus lower ACR tertiles  
Compared to the lower tertiles, the upper tertile group had significantly faster HR and 
lower HRV (SDNN, RMSSD, TI) (Table 2). ACR group remained significantly 
associated with HR, SDNN and RMSSD in multivariable analysis (Table 3). ACR 
group was a significant explanatory variable, independent of HbA1c, for heart rate 
and two measures of overall heart rate variability (SDNN and RMSSD); and 
independent of age and HbA1c for heart rate and RMSSD (Table 3).  
The marginal means of heart rate and RMSSD for the two ACR groups at four 
arbitrary age points are graphically represented in Figure 1 (a) and (b), 
demonstrating the decrease in heart rate and heart rate variability with age. 
Compared with controls, adolescents with diabetes had faster heart rate, lower 
overall heart rate variability (SDNN, RMSSD and TI) and higher sympathetic tone 
(LF:HF ratio) in comparison to age-matched controls (Appendix: Table S1) (10). 
 
Conclusions  
In this multicentre study of young adolescents with type 1 diabetes, we found 
significant differences in cardiac autonomic profile according to albumin excretion 
phenotype. Adolescents with a greater risk of later nephropathy also had lower 
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overall heart rate variability and higher resting heart rate, compared to those at lower 
risk of nephropathy; indicating that autonomic dysfunction is associated with future 
risk of nephropathy prior to the development of microalbuminuria. Furthermore, it is 
possible that the autonomic dysregulation contributes to renal dysfunction. 
This is the first large-scale study examining heart rate variability in relation to risk of 
nephropathy in adolescents with type 1 diabetes who have not yet developed 
microalbuminuria. Reduced heart rate variability has been associated with 
microalbuminuria in older adolescents (4; 9). In the SEARCH study, lower SDNN 
(one measures of overall heart rate variability) was associated with microalbuminuria 
in older adolescents with type 1 diabetes (mean age 18.8 years and mean duration 
9.8 years) (9). In this current study, we found significantly lower SDNN, RMSSD,  
(measures of overall heart rate variability) and faster heart rate in younger 
adolescents at risk of nephropathy (mean age 14.1 years, mean duration 6.4 years). 
Adult studies in type 1 diabetes demonstrate an early disturbance in cardiac 
autonomic function prior to onset of microalbuminuria. Higher 24 hour ambulatory 
blood pressure and reduced heart rate variability were detected in normoalbuminuric 
adults with type 1 diabetes with high-normal albumin excretion (above the median of 
4.2mcg/min) compared to those with low-normal albumin excretion (17). These 
changes occurred in the context of significantly worse glycemic control in the group 
with high-normal albumin excretion; in contrast our findings were independent of 
HbA1c.  
 
It is clear that glycemic control contributes to both autonomic dysfunction and other 
microvascular complications (18). Our study nevertheless demonstrated significant 
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differences in heart rate variability between the two risk groups despite similar mean 
HbA1c. Furthermore, heart rate, SDNN and RMSSD remained significant after 
adjustment for HbA1c in multivariable analysis. However, the association between 
ACR group and another measures of overall heart rate variability (TI) was weakened 
after adjustment for HbA1c, suggesting that HbA1c does modify the relationship 
between some measures of cardiac autonomic dysfunction and albumin excretion.  
 
Obesity has been associated with reduced parasympathetic activity and relative 
increase in sympathetic activity in adolescents with and without diabetes (10; 19). In 
contrast, we found was no significant difference in BMI SDS in the ACR groups to 
explain HRV differences between upper and lower ACR tertiles. The lack of 
difference in BMI SDS in the two groups helps exclude the confounding effect of 
obesity on autonomic function and albumin excretion in this cohort. 
 
Although systolic and diastolic blood pressures were significantly higher in the upper 
tertile ACR group in our study, the majority of adolescents in both ACR groups had 
blood pressure within the normotensive range for age and gender. Whilst 
adolescents with type 1 diabetes with microalbuminuria have higher blood pressure 
than those with normoalbuminuria (20; 21), there are mixed data on the detection of 
higher incident blood pressure prior to elevation in albumin excretion. In the T1D 
Exchange Clinic Registry, higher diastolic blood pressure in adolescents was a risk 
factor for microalbuminuria (22), whereas another study showed that higher incident 
blood pressure did not precede the onset of increasing albumin excretion (23). High 
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daytime blood pressure may therefore be a relatively late clinical finding in the 
progression of abnormal albumin excretion. 
 
Ambulatory blood pressure may better predict nephropathy risk in adolescent 
diabetes than incident blood pressure (21; 24). Furthermore, increase in nocturnal 
systolic blood pressure preceded the progression to microalbuminuria, and loss of 
nocturnal dip in blood pressure predicted the development of microbuminuria in 
adolescents with type 1 diabetes (25). As elevation in nocturnal systolic blood 
pressure and loss of nocturnal blood pressure dip can signify autonomic dysfunction 
(26), we therefore speculate that autonomic dysfunction may even precede the 
elevation of ACR into the higher risk tertile in this young population with type 1 
diabetes.  
 
It has been proposed that autonomic dysfunction plays a causative role in renal 
disease, through changes in nocturnal glomerular function and renal hemodynamics 
(6; 27) or a loss of protective effect on the kidneys leading to progression of renal 
disease (6; 28; 29). Animal data support the role of increased sympathetic activity in 
the pathogenesis of renal disease (30). A recent study of adults with type 2 diabetes 
found that cardiac autonomic dysfunction was associated with increased albuminuria 
and lower estimated glomerular filtration rate (eGFR) at baseline, and also predicted 
subsequent decline in eGFR (31). Clinical studies in adults with type 1 diabetes have 
been less clear on the role of cardiac autonomic function on renal decline (28; 29; 
32). In adolescents with type 1 diabetes, there is evidence for autonomic 
dysregulation occurring early in the pathogenesis of microvascular complications. 
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We previously found that abnormal pupillary response, a marker of autonomic 
dysfunction, preceded development of microalbuminuria and diabetic retinopathy 12 
years later (33).  
 
A limitation of this study is its cross-sectional nature; thus it cannot examine 
causative and temporal relationships between albumin excretion and the autonomic 
function. Autonomic dysfunction and abnormal albumin excretion may also share 
common etiology not formally measured in this study, such as insulin resistance (34; 
35) and biochemical mediators of inflammation (36-38). Strengths of this study 
include the large participant recruitment and standardised methodology, heart rate 
variability analysis by one operator, and careful clinical characterisation for eligibility 
into a follow up randomised controlled trial (AdDIT).  
 
This study elucidates the adverse heart rate variability profile already present in 
young adolescents with type 1 diabetes identified to be at higher risk of nephropathy. 
Longitudinal analysis of these patients will determine possible early predictive value 
of heart rate variability in addition to albumin excretion phenotype on renal and 
cardiac outcomes.  
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Figure Legend 
Abbreviations: RMSSD root mean squared difference of successive NN-intervals 
Legend: black circles = lower ACR tertiles; black squares = upper ACR tertile 
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Table 1: Participant characteristics stratified by urine albumin:creatinine ratio (ACR) 
tertiles 
 Lower ACR tertiles Upper ACR tertile P value 
N (% male) 217 (54%) 228 (50%) 0.45 
Age (years) 14.6 (1.5) 14.1 (1.5) <0.01 
Height SDS 0.38 (1.06) 0.38 (0.97) 1.00 
Weight SDS 0.77 (0.77) 0.67 (0.89)  0.21 
BMI SDS 0.67 (0.80) 0.55 (0.90)  0.14 
Duration (years) 7.6 (3.4) 6.4 (3.0) <0.01 
HbA1c (%) 8.3 (1.2) 8.5 (1.4) 0.07  
HbA1c (mmol/mol) 67 (13) 69 (15) 0.07 
eGFR 122 (22) 132 (25) <0.01 
Mean SBP (mmHg) 114 (11) 118 (13) <0.01 
Mean DBP (mmHg) 64 (20) 67 (8) 0.09 
SBP SDS 0.36 (0.86) 0.78 (1.03) <0.01 
DBP SDS 0.20 (1.88) 0.40 (0.77) <0.01 
Cholesterol (mmol/L) 4.5 (0.9) 4.5 (0.9) 0.64 
HDL-cholesterol (mmol/L) 1.45 (0.34) 1.54 (0.35) 0.02 
Triglycerides (mmol/L) 1.1 (0.7) 1.2 (0.8) 0.75 
LDL-cholesterol (mmol/L) 2.5 (0.8) 2.4 (0.7) 0.31 
 
Abbreviations: ACR standardized albumin:creatinine ratio; SDS standard deviation scores; 
BMI body mass index; eGFR estimated glomerular filtration rate; SBP systolic blood 
pressure; DBP diastolic blood pressure; HDL-cholesterol high-density lipoprotein cholesterol; 
LDL-cholesterol low-density lipoprotein cholesterol. Data are presented as mean (standard 
deviation) 
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Table 2: Heart rate variability (HRV) in adolescents with type 1 diabetes stratified by 
urine albumin:creatinine ratio (ACR) tertiles 
HRV Parameter Lower ACR tertiles Upper ACR tertile P value 
Heart rate (bpm) 73 (12) 76 (13) <0.01 
SDNN (ms) 76 (36) 68 (30) 0.02 
RMSSD (ms) 71 (49) 63 (43) 0.04 
LF Power 1839 (2282) 1363 (1237) <0.01 
HF Power  2439 (3751) 2076 (3229) 0.27 
LF:HF ratio 1.3 (1.2) 1.5 (1.3) 0.14 
TI 17 (7) 15 (6) 0.04 
 
Abbreviations: HRV heart rate variability; HR heart rate; SDNN standard deviation of mean 
NN intervals; RMSSD root mean squared difference of successive NN-intervals; LF low 
frequency; HF high frequency; TI triangular index; ACR standardized urine 
albumin:creatinine ratio.  
Data are presented as mean (standard deviation) 
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Table 3: Multivariable analysis of heart rate variability (HRV) outcomes and ACR tertiles 
HRV parameter Factor* B (95% CI) P value 
HR Upper ACR tertile+  
Age 
HbA1c 
2.5 (0.2 to 4.8) 
-1.2 (-1.9 to -0.4) 
1.9 (1.0 to 2.8) 
0.03 
<0.01 
<0.001 
SDNN 
 
Upper ACR tertile  
HbA1c 
-6.6 (-12.7 to -0.4) 
-3.8 (-6.2 to -1.4) 
0.04 
<0.01 
RMSSD Upper ACR tertile 
Age  
HbA1c 
-9.5 (-18.2 to -0.8) 
-3.1 (-6.0 to -0.3) 
-3.9 (-7.2 to -0.5) 
0.03 
0.03 
0.02 
 
Abbreviations: HRV heart rate variability; HR heart rate; SDNN standard deviation of mean 
NN intervals; RMSSD root mean squared difference of successive NN-intervals; ACR 
standardized albumin:creatinine ratio.  
*Diabetes duration, BMI SDS, systolic or diastolic BP SDS were not significant explanatory 
variables in the above models 
+Reference group is lower tertiles 
 
